In addition, a small percentage of familial PAH cases are attributed to mutations in TGF-β family receptor members or related downstream signaling proteins (e.g., ACVRL1/ALK1, endoglin/ENG, and SMAD9) [43]. The gene discussed is ACVRL1; the disease is pulmonary arterial hypertension.